Edward Chesney

King’s College London

United Kingdom

Research Interests

Explore related searches

Professors in United Kingdom

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

Articles (10)

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2022

Year:

2022

Collaborators (15)

Will Lawn

King’s College London

UNITED KINGDOM

View details

Louise Birkedal Glenthøj

Københavns Universitet

DENMARK

View details

Paolo Fusar-Poli

King’s College London

UNITED KINGDOM

View details

Daniel Stahl

King’s College London

UNITED KINGDOM

View details

David Taylor

King’s College London

UNITED KINGDOM

View details

Lucia Valmaggia

King’s College London

UNITED KINGDOM

View details

Uzma Zahid

King’s College London

UNITED KINGDOM

View details

Tom Spencer

King’s College London

UNITED KINGDOM

View details

Paris Alexandros Lalousis

University of Birmingham

UNITED KINGDOM

View details

John Hodsoll

King’s College London

UNITED KINGDOM

View details

robin murray

King’s College London

UNITED KINGDOM

View details

Philip McGuire

King’s College London

UNITED KINGDOM

View details

John Strang

UNITED KINGDOM

View details

Mark van der Gaag

University of Amsterdam

NETHERLANDS

View details

Robert McCutcheon

King’s College London

UNITED KINGDOM

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Edward Chesney

Research Interests

Explore related searches

Contact this professor

Articles (10)

Exploring the relationship between frequent cannabis use, belief updating under uncertainty and psychotic-like symptoms

Exploring causal mechanisms of psychosis risk

Assessing Cannabis Use in People with Psychosis

Cannabidiol does not attenuate acute delta‐9‐tetrahydrocannabinol‐induced attentional bias in healthy volunteers: A randomised, double‐blind, cross‐over study

Influence of cannabis use on incidence of psychosis in people at clinical high risk

THE ACUTE EFFECTS OF CANNABIS WITH AND WITHOUT CANNABIDIOL IN ADULTS AND ADOLESCENTS

Point of care assay for blood aripiprazole concentrations: development, validation and utility

Does cannabidiol make cannabis safer? A randomised, double-blind, cross-over trial of cannabis with four different CBD:THC ratios

Acceptability of point of care testing for antipsychotic medication levels in schizophrenia

Acceptability of cannabidiol in patients with psychosis

Collaborators (15)

Will Lawn

Louise Birkedal Glenthøj

Paolo Fusar-Poli

Daniel Stahl

David Taylor

Lucia Valmaggia

Uzma Zahid

Tom Spencer

Paris Alexandros Lalousis

John Hodsoll

robin murray

Philip McGuire

John Strang

Mark van der Gaag

Robert McCutcheon

Make your next move.